Open access

Coronary Artery Bypass Grafting Without Cardiopulmonary Bypass and Without Aortic Manipulation

Written By

José Glauco Lobo Filho, Heraldo Guedis Lobo Filho and Eduardo Rebouças Carvalho

Submitted: June 11th, 2012 Published: February 26th, 2014

DOI: 10.5772/57115

Chapter metrics overview

1,800 Chapter Downloads

View Full Metrics

1. Introduction

The methods for coronary artery bypass grafting (CABG) have evolved rapidly in recent years. Procedures such as the CABG without cardiopulmonary bypass (CPB), non-handling of the ascending aorta (AA) and the search for better grafts are strategies that aim at reducing the morbidity and mortality in the immediate postoperative period, the reduction of hospital stay and the increase in expectation and quality of life of patients on long-term [1].

It is known that changes, especially at the cellular level, resulting from the blood flow by non-endothelial surfaces in cardiopulmonary bypass (CPB), trigger the systemic inflammatory response syndrome [2, 3]. The use of CPB, and inflammatory disorders, can cause coagulation disorders with procoagulant effects and may cause early obstruction of the grafts [4], cerebral embolic events with irreversible neurological damage [5-8], and susceptibility to infectious processes due to immune depression in postoperative period [9].

The handling of AA is intrinsically related to the occurrence of cerebrovascular accident (stroke), especially in elderly patients, either at the time of cannulation, clamping and unclamping of the aorta to the installation and maintenance of the CPB circuit, to carry out the proximal anastomosis of vascular grafts [10-12]. Some studies show that the handling of AA is not the most important factor in reducing neurological complications [13, 14].

Another important factor for the improvement of CABG in the long term is the selection of the grafts and the configuration thereof. It should be taken into account the specific anatomical and clinical conditions of each patient and the surgical team's experience in obtaining, preparation and anastomosis of the grafts.

The use of composite graft setting in "Y", the left internal thoracic artery (LITA) with arterial segments or segments of great saphenous vein (GSV) to revascularize both the left coronary system (LCS) as the right is a technique widely described in literature, especially in patients at high risk of stroke [15]. This procedure can be performed without CPB and without manipulation of the AA, being the LITA the main source of blood supply to more than one coronary artery. The LITA, in turn can also be used sequentially to the grafting of two or three arteries of the left anterior descending artery (AD), being able to provide adequate blood supply for the entire LCS, both at rest and stress [16].

Although the use of the GSV as aortocoronary graft is related to higher incidence of obstructions than arterial grafts, especially the LITA, in short, medium and long-term disease called aorto-coronary vein graft [17], it seems likely that the use valveless GSV segments in combination with the LITA may modify these results [18, 19]. In our department we use routinely a composite graft of LIMA and valveless GSV, in "Y" for the revascularization of arteries of the LCS.

Advertisement

2. Surgical technique for CABG without CPB and without AA manipulation using composite graft

After electrocardiographic monitoring of central venous pressure and mean arterial pressure, the patient is anesthetized. Proceeding to the opening of the chest (sternotomy or left thoracotomy), exposing finally the heart, the pericardium by setting the drapes. The LITA is completely dissected from its origin until the seventh intercostal space, making up ligation of all branches possible with a metal clip. Obtaining the saphenous vein graft is done preferentially by endoscopic dissection [20]. The procedure is anticoagulation by intravenous administration of sodium heparin at doses of 1.0 mg / kg body weight, with accurate control of the activated clotting time, which must be greater than 200 seconds [21]. We emphasize that both the perfusionist as all the equipment for immediate installation of the CPB circuit is available to the surgical team.

Being the grafts properly prepared, the coronary arteries to be grafted are dissected. The interruption of blood flow to regions of the coronary arteries, where anastomosis shall be made is performed by passing a 5-0 polypropylene line, in eight, with tourniquets proximal and distal to the anastomosis site. Among the coronary and tourniquets, in order to protect the coronary arterial bed, it is interposed a small segment (1.0 cm) of silicone tubes (Figure 1). The intracoronary perfusates are only used in special situations.

Figure 1.

Protection of the coronary arterial bed with a small silicone tube segment number 10 on the occasion of the coronary tourniquet. Device for stabilizing tissue in the anastomosis.

The coronary artery is incised longitudinally, and anastomosis performed with the aid of a tissue stabilizer (Figure 1), using a single polypropylene line 7-0 or 8-0 in cases of venous grafts and 8-0 in the case of arterial grafts. Invariably, the LITA is anastomosed to the AD, and one segment GSV, originating from the side of the LITA, revascularizes a second branch of the LCS (Figures 2 and 3). For revascularization of the posterior arteries, we used the Lima Point, which facilitates the rotation of the mediastinum to the right [22].

Figure 2.

Schematic of a composite graft of LITA with GSV revascularizing the AD and a marginal circumflex artery, respectively

Figure 3.

Angiographic study of a composite graft of LITA revascularizing AD and one segment GSV originated from a LITA revascularizing the circumflex marginal artery. Left anterior oblique cranial flow.

Figure 4.

Schematic of a composite graft of LITA revascularizing AD and a GSV segment derived from the LITA revascularizing the 1st Diagonal and a second segment originating from GSV revascularizing a diagonal of the circumflex marginal artery.

When other branches need to be revascularized, a second vein segment stems from the anterior side of the vein segment (Figures 4 and 5). The venous segment can also be anastomosed sequentially. The evaluation of the flow of the grafts after preparing the same, using flowmetry instruments is of paramount importance, being routinely performed in various facilities.

Figure 5.

Angiography of a composite graft of LITA revascularizing AD and a GSV segment derived from the LITA revascularizing the 1st Diagonal and a second segment originating from the GSV revascularizing a diagonal of the circumflex marginal artery. Examination 11 years after surgery.

Advertisement

3. Final considerations

In our department, since the mid-1990s, is routinely performed Off Pump Coronary artery Bypass (OPCAB) surgery in 92% of patients with stable coronary artery disease. This associated with the frequent use of LITA grafts composed of GSV and arteries for revascularization of the LCS, with excellent results in terms of morbidity and Doppler or angiographic evaluation of grafts in the short, medium and long term [23-25].

In the preoperative approach of patients we considered critically important the nutritional and medicinal aspects. The reduction of sodium intake and calorie foods, weight loss, regarding the increase of food of real nutrition and immunomodulator value are important. The administration of statins, acetylsalicylic acid (ASA), beta-blockers is maintained until the day before surgery, because they are related to the reduction of inflammatory response, lower incidence of early thrombosis of grafts and prevention of atrial fibrillation in the post- surgery. Glycemic control is done strictly to prevent infectious complications [26].

Regarding the preoperative examinations all patients underwent echocardiography, Doppler study by the carotid and vertebral arteries and the venous system of lower limbs and abdominal ultrasound evaluation, for abdominal aortic aneurysm screening.

Regarding the operative aspects, we think the two biggest factors that increase morbidity and mortality in CABG surgery is the use of CPB and the handling of AA. The CPB, as has been explained, is related to inflammatory changes that may result in exacerbated systemic inflammatory response syndrome affecting multiple organic. Studies clearly demonstrate the association of CPB with brain [27], lung [28], kidney [29] and gastrointestinal [30] damage.

The CPB is still associated with higher levels of bleeding during and after surgery and therefore with greater administration of blood products [31]. The use of these agents in turn, its associated, in addition to the known complications of immunologic and infectious nature, to the lower long-term survival [32]. Another important fact is that in OPCAB the dose of heparin required for anticoagulation is small enough to achieve an activated clotting time greater than 200 seconds, thus the dose of protamine administered at the end of the procedure will be lower, because this drug is related to a series of negative effects on the hemodynamic and inflammatory aspect [33].

The handling of AA, as well discussed, is intrinsically linked to embolic events when there is atheromatous disease of the ascending aorta. However, beyond this fact, the partial or total clamping of the aorta can cause aortic dissection [34].

In an era when one seeks a broader use of arterial grafts one might ask why the routine use of GSV associated with LITA. First one must take into account the morbidity associated with obtaining the grafts. Mediastinitis is a terrible complication associated with increased mortality, with devastating consequences to the physical and psychological integrity of the patient as well as repercussions in terms of financial cost on the public or private health system [35]. The use of two LITAs doubles the risk of internal thoracic mediastinitis compared to the use of a single LITA [36] and can increase up to fourteen times the risk of this complication associated with diabetes mellitus [37].

Regarding the use of the radial artery it is described that its dissection causes neurological complications in about 30 percent of patients [38]. The radial artery is an artery muscle spasm and susceptible to atrophy, especially when used to revascularize the coronary arteries without severe stenosis [39, 40]. It is noteworthy that the angiographic results of radial artery grafts are not superior to that of GSV grafts [41]. Obtaining gastroepiploic artery, in turn, brings the disadvantage of opening of the peritoneal cavity, and similarly to the radial artery, it is prone to spasm and thus it is only used for the revascularization of severe stenosed arteries [42].

Obtaining the GSV causes minimal morbidity, especially when done in an endoscopic manner. It is a long graft, easy to handle and has no tendency to spasm. We consider of utmost importance the venous Doppler study of lower limb in order to ascertain the GSV along its entire length, the presence of valves and varicosities, and mark its location to better perform the incisions for the dissection, with less tissue trauma and preservation of cosmetic and finally the possibility of the preoperative preparation of another option, in those patients in which GSV is not considered appropriate [43].

The obstruction of the GSV grafts occurs mainly by the action of three factors, which are thrombosis, intimal hyperplasia and atherosclerosis [4, 44]. We think that the saphenous vein, the way we use it, can have a better behavior than those currently described, for the following reasons:

  1. The CABG procedure performed without CPB and, especially in the presence of AAS, has a lower prothrombotic nature, which should be associated with lower rates of occlusion of graft thrombosis [45].

  2. The SV segments that we use are small and without valves, reducing the resistance to blood flow and eliminating sites (valves) that favor the development of stenosis [4, 18, 46];

  3. Lower blood pressure and circulatory stress imposed on segments of the saphenous vein from the LITA, compared to those originating from the aorta, might cause less damage to the intimate, less development of intimal hyperplasia and atherosclerosis [47, 48];

  4. As the endothelium of the LITA is a major producer of nitric oxide, we believe that the SV graft, originating from this artery, may receive part of this hormone, thereby decreasing the incidence of atherosclerotic disease [44, 49];

  5. hemodynamically the presence of the valve in the GSV segment can primarily cause entrapment of blood between the coronary anastomosis and the valve due to the phenomenon of flow, natural in the blood circulatory system, with increasing pressure during diastole with consequent stagnation of flow in venous segment; secondarily this flow stagnation limits the infusion, in order to generate a vicious cycle, leading to obstruction of the graft. This mechanism becomes responsible for 20% of cases of graft failure following a year [18, 46].

In order to reduce the heart rate and decrease the energy consumption of the cardiomyocyte during anastomoses, especially of the LITA to the AD, we administered esmolol, beta-blocker of quick action, which has duration of action of about nine minutes. We believe that the use of this drug to integrates the concept of myocardial protection in CABG surgery without CPB [50].

The increasing popularity of off-pump CABG surgery has brought concern, especially in groups that start in the use of this technique, with the quality of anastomoses. Methods for verification of graft patency in the intraoperative period are not commonly performed, and most cardiovascular surgeons rely on electrocardiographic criteria, and hemodynamic enzyme to make a diagnosis of early occlusion of grafts. The use of Transit-time flowmetry has been adopted in many centers for CABG surgery with or without CPB [51].

In cases of elective surgery, epidural anesthesia with opioids and local anesthetic is routinely performed. This procedure has a number of benefits beyond the appropriate component of postoperative analgesia, such as increasing the diameter of epicardial arteries, improves flow through collateral circulation, reduction of myocardial oxygen demand, decreased arrhythmias, lower rates of sternum infection and modulation of inflammatory activity [52, 53].

For the future we aim to allow our patients the benefits of revascularization by left minithoracotomy with the aid of thoracoscopy [54] for cases of revascularization of arteries of the LCS with or without percutaneous treatment of lesions of the right coronary artery or other vessels [55]. We are still attentive to the evolution of epicardial ablation treatment for atrial fibrillation [56], as well as the development of efficient devices to exclude the left atrial appendage, focus formation and embolization of 60-91%% of thrombi causing embolic ischemic stroke in validity of this tachyarrhythmia [57].

Finally, we believe that surgical revascularization of the LCS can be systematically performed without CPB and without manipulation of the AA, in order to reduce the systemic inflammatory response, blood transfusion, and mortality, particularly related to neurological complications. Furthermore, the use of a valveless GSV grafts associated with LITA for coronary artery bypass grafting of the LCS simplifies the technique of anastomosis "Y", making it more physiological and, it may also be associated with a higher rate of graft patency in the long term.

References

  1. 1. Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons. Journal of the American College of Cardiology. 2011;58[24):e123-210. Epub 2011/11/11.
  2. 2. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. The Journal of thoracic and cardiovascular surgery. 1983;86[6):845-57. Epub 1983/12/01.
  3. 3. Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. The Annals of thoracic surgery. 2000;69[4):1198-204. Epub 2000/05/09.
  4. 4. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. Circulation. 1998;97[9):916-31. Epub 1998/04/01.
  5. 5. Blauth CI, Arnold JV, Schulenberg WE, McCartney AC, Taylor KM. Cerebral microembolism during cardiopulmonary bypass. Retinal microvascular studies in vivo with fluorescein angiography. The Journal of thoracic and cardiovascular surgery. 1988;95[4):668-76. Epub 1988/04/01.
  6. 6. Harringer W. Capture of particulate emboli during cardiac procedures in which aortic cross-clamp is used. International Council of Emboli Management Study Group. The Annals of thoracic surgery. 2000;70[3):1119-23. Epub 2000/10/04.
  7. 7. Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, et al. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. The New England journal of medicine. 2001;344[6):395-402. Epub 2001/02/15.
  8. 8. Groom RC, Quinn RD, Lennon P, Welch J, Kramer RS, Ross CS, et al. Microemboli from cardiopulmonary bypass are associated with a serum marker of brain injury. The Journal of extra-corporeal technology. 2010;42[1):40-4. Epub 2010/05/05.
  9. 9. Akbas H, Erdal AC, Demiralp E, Alp M. Effects of coronary artery bypass grafting on cellular immunity with or without cardiopulmonary bypass: changes in lymphocytes subsets. Cardiovascular surgery (London, England). 2002;10[6):586-9. Epub 2002/11/28.
  10. 10. Barbut D, Hinton RB, Szatrowski TP, Hartman GS, Bruefach M, Williams-Russo P, et al. Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke; a journal of cerebral circulation. 1994;25[12):2398-402. Epub 1994/12/01.
  11. 11. Dietl CA, Madigan NP, Laubach CA, Chapman JH, Bering JP, Holcomb PH, et al. Myocardial revascularization using the "no-touch" technique, with mild systemic hypothermia, in patients with a calcified ascending aorta. The Journal of cardiovascular surgery. 1995;36[1):39-44. Epub 1995/02/01.
  12. 12. Trehan N, Mishra M, Kasliwal RR, Mishra A. Surgical strategies in patients at high risk for stroke undergoing coronary artery bypass grafting. The Annals of thoracic surgery. 2000;70[3):1037-45. Epub 2000/10/04.
  13. 13. Lev-Ran O, Loberman D, Matsa M, Pevni D, Nesher N, Mohr R, et al. Reduced strokes in the elderly: the benefits of untouched aorta off-pump coronary surgery. The Annals of thoracic surgery. 2004;77[1):102-7. Epub 2004/01/17.
  14. 14. Misfeld M, Potger K, Ross DE, McMillan D, Brady PW, Marshman D, et al. "Anaortic" off-pump coronary artery bypass grafting significantly reduces neurological complications compared to off-pump and conventional on-pump surgery with aortic manipulation. The Thoracic and cardiovascular surgeon. 2010;58[7):408-14. Epub 2010/10/06.
  15. 15. Wendler O, Hennen B, Markwirth T, Konig J, Tscholl D, Huang Q, et al. T grafts with the right internal thoracic artery to left internal thoracic artery versus the left internal thoracic artery and radial artery: flow dynamics in the internal thoracic artery main stem. The Journal of thoracic and cardiovascular surgery. 1999;118[5):841-8. Epub 1999/10/27.
  16. 16. Lobo Filho JG, Leitão MCdA, Lobo Filho HG, Silva AAd, Machado JJA, Forte AJdV, et al. Revascularização miocárdica com enxerto composto de artéria torácica interna esquerda em Y: análise de fluxo sangüíneo. Revista Brasileira de Cirurgia Cardiovascular. 2004;19:1-8.
  17. 17. Sabik JF, 3rd, Lytle BW, Blackstone EH, Houghtaling PL, Cosgrove DM. Comparison of saphenous vein and internal thoracic artery graft patency by coronary system. The Annals of thoracic surgery. 2005;79[2):544-51; discussion -51. Epub 2005/02/01.
  18. 18. Lajos TZ, Robicsek F, Thubrikar M, Urschel H. Improving patency of coronary conduits "valveless" veins and/or arterial grafts. Journal of cardiac surgery. 2007;22[2):170-7. Epub 2007/03/07.
  19. 19. Hwang HY, Kim JS, Kim KB. Angiographic equivalency of off-pump saphenous vein and arterial composite grafts at one year. The Annals of thoracic surgery. 2010;90[2):516-21. Epub 2010/07/30.
  20. 20. Black EA, Campbell RK, Channon KM, Ratnatunga C, Pillai R. Minimally invasive vein harvesting significantly reduces pain and wound morbidity. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2002;22[3):381-6. Epub 2002/09/03.
  21. 21. Lobo Filho JG, Leitão MC, Lobo RAM, Lima Júnior JMd, Ribeiro JPA, Cavalcante F, et al. Padronização da dose de heparina sódica utilizada na cirurgia de revascularização do miocárdio sem circulação extracorpórea. Revista Brasileira de Cirurgia Cardiovascular. 2005;20:279-85.
  22. 22. Lima RC. Padronização técnica de revascularização miocárdica da artéria circunflexa e seus ramos sem circulação extracorpórea. São Paulo. Tese [Doutorado]. Escola Paulista de Medicina da USP; 1999.
  23. 23. Lobo Filho JG, Dantas MCBR, Rolim JGV, Rocha JA, Oliveira FM, Ciarline C, et al. Cirurgia de revascularização completa do miocárdio sem circulação extracorpórea: uma realidade. Rev Bras Cir Cardiovasc. 1997;12:7.
  24. 24. Lobo Filho JG, Leitao MC, Lobo Filho HG, Soares JPH, Magalhães GA, Leao Filho CSC, et al. Cirurgia de revascularização coronariana esquerda sem CEC e sem manuseio da aorta em pacientes acima de 75 anos: análise das mortalidades imediata e a médio prazo e das complicações neurológicas no pós-operatório imediato. Rev Bras Cir Cardiovasc. 2002;17:6.
  25. 25. Lobo Filho JG, Leitao MC, Forte AJ, Filho HG, Silva AA, Bastos ES, et al. Flow analysis of left internal thoracic artery in myocardial revascularization surgery using y graft. Texas Heart Institute journal / from the Texas Heart Institute of St Luke's Episcopal Hospital, Texas Children's Hospital. 2006;33[4):430-6. Epub 2007/01/12.
  26. 26. Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y, et al. Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. European heart journal. 2006;27[22):2716-24. Epub 2006/04/13.
  27. 27. Taylor KM. Brain damage during cardiopulmonary bypass. The Annals of thoracic surgery. 1998;65[4 Suppl):S20-6; discussion S7-8. Epub 1998/05/01.
  28. 28. Apostolakis EE, Koletsis EN, Baikoussis NG, Siminelakis SN, Papadopoulos GS. Strategies to prevent intraoperative lung injury during cardiopulmonary bypass. Journal of cardiothoracic surgery. 2010;5:1. Epub 2010/01/13.
  29. 29. Abu-Omar Y, Ratnatunga C. Cardiopulmonary bypass and renal injury. Perfusion. 2006;21[4):209-13. Epub 2006/08/31.
  30. 30. Sinclair DG, Haslam PL, Quinlan GJ, Pepper JR, Evans TW. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability. Chest. 1995;108[3):718-24. Epub 1995/09/01.
  31. 31. Coakley M, Hall JE, Evans C, Duff E, Billing V, Yang L, et al. Assessment of thrombin generation measured before and after cardiopulmonary bypass surgery and its association with postoperative bleeding. Journal of thrombosis and haemostasis : JTH. 2011;9[2):282-92. Epub 2010/11/26.
  32. 32. Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. The Annals of thoracic surgery. 2002;74[4):1180-6. Epub 2002/10/29.
  33. 33. Viaro F, Dalio MB, Evora PR. Catastrophic cardiovascular adverse reactions to protamine are nitric oxide/cyclic guanosine monophosphate dependent and endothelium mediated: should methylene blue be the treatment of choice? Chest. 2002;122[3):1061-6. Epub 2002/09/13.
  34. 34. Litchford B, Okies JE, Sugimura S, Starr A. Acute aortic dissection from cross-clamp injury. The Journal of thoracic and cardiovascular surgery. 1976;72[5):709-13. Epub 1976/11/01.
  35. 35. Nina VJdS, Assef MAS, Rodrigues RR, Mendes VGG, Lages JS, Amorim ÂMM, et al. Reconstrução da parede torácica com suporte metálico externo: técnica alternativa na mediastinite pós-esternotomia. Revista Brasileira de Cirurgia Cardiovascular. 2008;23:507-11.
  36. 36. Grossi EA, Esposito R, Harris LJ, Crooke GA, Galloway AC, Colvin SB, et al. Sternal wound infections and use of internal mammary artery grafts. The Journal of thoracic and cardiovascular surgery. 1991;102[3):342-6; discussion 6-7. Epub 1991/09/01.
  37. 37. Borger MA, Rao V, Weisel RD, Ivanov J, Cohen G, Scully HE, et al. Deep sternal wound infection: risk factors and outcomes. The Annals of thoracic surgery. 1998;65[4):1050-6. Epub 1998/05/16.
  38. 38. Denton TA, Trento L, Cohen M, Kass RM, Blanche C, Raissi S, et al. Radial artery harvesting for coronary bypass operations: neurologic complications and their potential mechanisms. The Journal of thoracic and cardiovascular surgery. 2001;121[5):951-6. Epub 2001/04/28.
  39. 39. Maniar HS, Sundt TM, Barner HB, Prasad SM, Peterson L, Absi T, et al. Effect of target stenosis and location on radial artery graft patency. The Journal of thoracic and cardiovascular surgery. 2002;123[1):45-52. Epub 2002/01/10.
  40. 40. Moran SV, Baeza R, Guarda E, Zalaquett R, Irarrazaval MJ, Marchant E, et al. Predictors of radial artery patency for coronary bypass operations. The Annals of thoracic surgery. 2001;72[5):1552-6. Epub 2001/11/28.
  41. 41. Locali RF, Buffolo E, Catani R. Artéria radial versus veia safena para revascularização do miocárdio: metanálise (não houve diferença estatisticamente significante). Revista Brasileira de Cirurgia Cardiovascular. 2006;21:255-61.
  42. 42. Glineur D, D'Hoore W, El Khoury G, Sondji S, Kalscheuer G, Funken JC, et al. Angiographic predictors of 6-month patency of bypass grafts implanted to the right coronary artery a prospective randomized comparison of gastroepiploic artery and saphenous vein grafts. Journal of the American College of Cardiology. 2008;51[2):120-5. Epub 2008/01/15.
  43. 43. BARROS FS, PONTES SM, LIMA ML, HENRIQUE JS, ROLDI ML, REIS F, et al. Mapeamento da safena interna com ecocolor Doppler no pré-operatório de cirurgia de revascularização miocárdica. Revista Brasileira de Cirurgia Cardiovascular. 1999;14:303-7.
  44. 44. Nwasokwa ON. Coronary artery bypass graft disease. Annals of internal medicine. 1995;123[7):528-45. Epub 1995/10/01.
  45. 45. Paparella D, Galeone A, Venneri MT, Coviello M, Scrascia G, Marraudino N, et al. Activation of the coagulation system during coronary artery bypass grafting: comparison between on-pump and off-pump techniques. The Journal of thoracic and cardiovascular surgery. 2006;131[2):290-7. Epub 2006/01/26.
  46. 46. Lajos TZ, Graham SP, Guntupalli M, Raza ST, Hasnain S. Comparison of long-term patency of "horseshoe" saphenous vein grafts with and without valves. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 1996;10[10):846-51. Epub 1996/01/01.
  47. 47. Nguyen HC, Grossi EA, LeBoutillier M, 3rd, Steinberg BM, Rifkin DB, Baumann FG, et al. Mammary artery versus saphenous vein grafts: assessment of basic fibroblast growth factor receptors. The Annals of thoracic surgery. 1994;58[2):308-10; discussion 10-1. Epub 1994/08/01.
  48. 48. Calafiore AM, Vitolla G, Iaco AL, Fino C, Di Giammarco G, Marchesani F, et al. Bilateral internal mammary artery grafting: midterm results of pedicled versus skeletonized conduits. The Annals of thoracic surgery. 1999;67[6):1637-42. Epub 1999/07/03.
  49. 49. Shuhaiber JH, Evans AN, Massad MG, Geha AS. Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2002;22[3):387-96. Epub 2002/09/03.
  50. 50. Chassot PG, van der Linden P, Zaugg M, Mueller XM, Spahn DR. Off-pump coronary artery bypass surgery: physiology and anaesthetic management. British journal of anaesthesia. 2004;92[3):400-13. Epub 2004/02/19.
  51. 51. D'Ancona G, Karamanoukian HL, Ricci M, Schmid S, Bergsland J, Salerno TA. Graft revision after transit time flow measurement in off-pump coronary artery bypass grafting. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2000;17[3):287-93. Epub 2000/04/12.
  52. 52. Kirno K, Friberg P, Grzegorczyk A, Milocco I, Ricksten SE, Lundin S. Thoracic epidural anesthesia during coronary artery bypass surgery: effects on cardiac sympathetic activity, myocardial blood flow and metabolism, and central hemodynamics. Anesthesia and analgesia. 1994;79[6):1075-81. Epub 1994/12/01.
  53. 53. Scott NB, Turfrey DJ, Ray DA, Nzewi O, Sutcliffe NP, Lal AB, et al. A prospective randomized study of the potential benefits of thoracic epidural anesthesia and analgesia in patients undergoing coronary artery bypass grafting. Anesthesia and analgesia. 2001;93[3):528-35. Epub 2001/08/29.
  54. 54. Lima LE, Nataf P, Lima AE, Franceschini IA, Gomes C, Paniagua P, et al. Técnica de revascularização miocárdica com uso de toracoscopia. Revista Brasileira de Cirurgia Cardiovascular. 1996;11:232-7.
  55. 55. DeRose JJ. Current state of integrated "hybrid" coronary revascularization. Seminars in thoracic and cardiovascular surgery. 2009;21[3):229-36. Epub 2009/11/28.
  56. 56. Ninet J, Roques X, Seitelberger R, Deville C, Pomar JL, Robin J, et al. Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: results of a multicenter trial. The Journal of thoracic and cardiovascular surgery. 2005;130[3):803-9. Epub 2005/09/13.
  57. 57. Gillinov AM. Advances in surgical treatment of atrial fibrillation. Stroke; a journal of cerebral circulation. 2007;38[2 Suppl):618-23. Epub 2007/01/31.

Written By

José Glauco Lobo Filho, Heraldo Guedis Lobo Filho and Eduardo Rebouças Carvalho

Submitted: June 11th, 2012 Published: February 26th, 2014